C-Myc Deregulation Is Involved in Melphalan Resistance of Multiple Myeloma: Role of PDGF-BB

International Journal of Immunopathology and Pharmacology
doi 10.1177/205873920601900107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

IL-6-induced Enhancement of C-Myc Translation in Multiple Myeloma Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

MNK Kinases Facilitate C-Myc IRES Activity in Rapamycin-Treated Multiple Myeloma Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

PDGF-BB Is the Key to Unlocking Pathological Angiogenesis in OA

Nature Reviews Rheumatology
Rheumatology
2020English

Treatment of Multiple Myeloma With VLA4-targeted Nanoparticles Delivering Novel C-Myc Inhibitor Prodrug

2012English

Downregulation of C-Myc Is Involved in TLR3-mediated Tumor Death of Neuroblastoma Xenografts

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2016English

Characterizing Melphalan Efficacy and Toxicity in Multiple Myeloma Patients With Renal Insufficiency

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Role for MicroRNAs in Regulating Glucocorticoid Response and Resistance in Multiple Myeloma

Hormones and Cancer
OncologyCancer ResearchEndocrinologyAutonomic SystemsEndocrineMetabolismDiabetes
2011English

Wogonin Inhibits Multiple Myeloma-Stimulated Angiogenesis via C-Myc/VHL/HIF-1α Signaling Axis

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy